Chemed Co. (NYSE:CHE - Get Free Report) CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the transaction, the chief executive officer now owns 102,679 shares in the company, valued at $60,957,441.93. This represents a 1.91 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of CHE stock traded up $6.72 on Friday, hitting $601.07. The stock had a trading volume of 25,249 shares, compared to its average volume of 97,193. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62. The stock's 50 day moving average is $552.41 and its 200-day moving average is $563.97. The firm has a market capitalization of $8.80 billion, a price-to-earnings ratio of 30.37, a P/E/G ratio of 2.15 and a beta of 0.43.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date is Monday, February 24th. Chemed's dividend payout ratio is presently 10.05%.
Separately, StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday.
Get Our Latest Report on CHE
A number of hedge funds have recently added to or reduced their stakes in CHE. UMB Bank n.a. lifted its holdings in shares of Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Atala Financial Inc bought a new position in shares of Chemed in the 4th quarter valued at about $29,000. CBIZ Investment Advisory Services LLC lifted its stake in shares of Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after purchasing an additional 22 shares during the period. Trust Co. of Vermont bought a new stake in shares of Chemed in the 4th quarter valued at about $34,000. Finally, Tortoise Investment Management LLC grew its stake in Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after acquiring an additional 34 shares during the period. 95.85% of the stock is currently owned by institutional investors.
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.